Document is current
Any future updates will be listed below
-
Authors
Amorim, Kaela
Vandewouw, Marlee M.
Huynh, Nhu
de Villa, Kathrina
Safati, Celine
Almonte, Aurora
Nicolson, Rob
Kelley, Elizabeth
Crosbie, Jennifer
Brian, Jessica
Anagnostou, Evdokia
Taylor, Margot J.
Sato, Julie
-
Funding
Funding for this research was provided by:
Ontario Brain Institute
- License Information
-
More Information
Article History
Received: 20 February 2025
Accepted: 3 July 2025
First Online: 20 July 2025
Declarations
:
: This study involves human participants and was approved by Holland Bloorview Kids Rehabilitation Hospital, Toronto (11–280); The Hospital for Sick Children, Toronto (1000012230); McMaster Children’s Hospital, Hamilton (12–050); Lawson Health Research Institute, London (103326); and Queen’s University, Kingston (6005107). All children and youth provided verbal assent, and parents gave written informed consent in accordance with the Declaration of Helsinki.
: Not applicable.
: EA has received grants from Roche and Anavex, served as a consultant to Roche, Quadrant Therapeutics, Ono, and Impel Pharmaceuticals, has received in-kind support from AMO Pharma and CRA-Simons Foundation, received royalties from APPI and Springer, received an editorial honorarium from Wiley, and has a patent for holly™ (formerly Anxiety Meter). All other authors declare that they have no competing interests.
